RE:RE:RE:PPI'm thinking Knight would be more than upset if that was the case.
At any rate, you will now tomorrow when you call
jammingthepipeline wrote: Who said that? If it's true, then it's a bad move from the company against the " small fish" . But I don't think it's true. Let them buy on the open market. Tomorrow I will call the office.
I
MONTREAL, QUEBEC--(Marketwired - Dec. 19, 2016) - Knight Therapeutics Inc. ("Knight") (TSX:GUD), a leading Canadian specialty pharmaceutical company, announced today that it invested $180,000 in 3D Signatures Inc. (TSX VENTURE:DXD) ("3DS") as part of a brokered private placement of approximately $3.9 million. As consideration, Knight received 240,000 common shares of 3DS and warrants to purchase an additional 240,000 shares of 3DS at an exercise price of $0.92 with an expiry date of December 16, 2018, subject to an acceleration clause.